product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Prolactin R Antibody (204) [DyLight 680]
catalog :
NBP2-89377FR
quantity :
0.1 ml
price :
539 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
DyLight680
clone name :
204
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP2-89377FR
SKU :
NBP2-89377FR
product name :
Prolactin R Antibody (204) [DyLight 680]
sizes available :
0.1 ml
description :
The Prolactin R Antibody (204) [DyLight 680] from NBP2-89377FR is a 6.7e-05 antibody to . This antibody reacts with human.
target :
Prolactin R
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
204
conjugate :
DyLight 680
all_available conjugate :
DyLight 680
dilution :
ELISA, Sandwich ELISA Detection
host :
Rabbit
immunogen :
This antibody was obtained from a rabbit immunized with purified, recombinant Human Prolactin R (Accession#: NP_000940.1; Met 1-Asp 234).
isotype :
IgG
purity :
Protein A purified
species :
Human
gene symbol :
PRLR
applications :
ELISA,Sandwich ELISA Detection
extended description :
Recombinant Monoclonal Antibody
USD :
539 USD
product details :
Recombinant Monoclonal Antibody
alt names :
delta 4-delta 7/11 truncated prolactin receptor, delta 4-SF1b truncated prolactin receptor, hPRL receptor, hPRLrI, PRL-R, prolactin receptor, prolactin receptor delta 7/11, secreted prolactin binding protein
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
browse more products
questions and comments
